Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001689548-23-000128
Filing Date
2023-08-09
Accepted
2023-08-09 08:31:44
Documents
61
Period of Report
2023-06-30

Document Format Files

Seq Description Document Type Size
1 10-Q prax-20230630.htm   iXBRL 10-Q 789794
2 EX-31.1 exhibit31120230630.htm EX-31.1 13044
3 EX-31.2 exhibit31220230630.htm EX-31.2 14363
4 EX-32.1 exhibit32120230630.htm EX-32.1 13361
  Complete submission text file 0001689548-23-000128.txt   4318005

Data Files

Seq Description Document Type Size
5 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT prax-20230630.xsd EX-101.SCH 31544
6 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT prax-20230630_cal.xml EX-101.CAL 47463
7 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT prax-20230630_def.xml EX-101.DEF 160518
8 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT prax-20230630_lab.xml EX-101.LAB 434739
9 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT prax-20230630_pre.xml EX-101.PRE 281013
55 EXTRACTED XBRL INSTANCE DOCUMENT prax-20230630_htm.xml XML 435599
Mailing Address 99 HIGH STREET, 30TH FLOOR BOSTON MA 02110
Business Address 99 HIGH STREET, 30TH FLOOR BOSTON MA 02110 617-300-8460
Praxis Precision Medicines, Inc. (Filer) CIK: 0001689548 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-39620 | Film No.: 231153509
SIC: 2834 Pharmaceutical Preparations